Archive | 2021
NGHIÊN CỨU CHU TRÌNH ĐÀO TẠO (LEARNING CURVE) PHẪU THUẬT RÔ BỐT DA VINCI XI ĐIỀU TRỊ UNG THƯ ĐẠI TRỰC TRÀNG TẠI BỆNH VIỆN K
Abstract
120 for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology. 2010;138 (1): 52-64. 3. Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Ymicrosphere selective internal radiation treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2010;51(8):1206-12. 4. Giammarile F, Bodei L, Chiesa C, Flux G, Forrer F, Kraeber-Bodere F, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. European journal of nuclear medicine and molecular imaging. 2011;38(7):1393-406. 5. Gil‐Alzugaray B, Chopitea A, Iñarrairaegui M, Bilbao JI, Rodriguez‐Fraile M, Rodriguez J, et al. Prognostic factors and prevention of radioembolization‐induced liver disease. Hepatology (Baltimore, Md). 2013;57(3):1078-87. 6. Gates VL, Esmail AA, Marshall K, Spies S, Salem R. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2011;52(1):72-6. 7. Lenoir L, Edeline J, Rolland Y, Pracht M, Raoul J-L, Ardisson V, et al. Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization. European journal of nuclear medicine and molecular imaging. 2012;39(5):872-80. 8. Garin E, Lenoir L, Rolland Y, Laffont S, Pracht M, Mesbah H, et al. Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90labeled microspheres. Nuclear medicine communications. 2011;32(12):1245-55.